Press Release

culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System – QNT Press Release

[ad_1]

GRAND RAPIDS, Mich., June 6, 2022 /PRNewswire/ — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for their Tapestry® RC System for Rotator Cuff Repair.

The novel design of the TAPESTRY® RC System combines an arthroscopic introducer pre-loaded with the TAPESTRY® biointegrative collagen implant and the first fully bioabsorbable fixation anchors FDA cleared for use for fixation in both tendon and bone in an easy-to-use, pre-loaded anchor inserter.

Embody is a privately-held medical device company developing novel collagen-based technologies for sports medicine and soft tissue repair. They are redefining the future of rotator cuff repair by combining a biointegrative collagen implant with streamlined arthroscopic delivery and fully bioabsorbable anchor fixation.

In 2021, there were an estimated 670,000 rotator cuff repairs in the United States.1 The goal of rotator cuff surgery is to repair the …

Full story available on Benzinga.com

[ad_2]

Source link

Related
2020 © Zeen World News